EDBI: A look back at 2023

EDBI: A look back at 2023

As we stand at the forefront of building successful and sustainable industries in Singapore, this year has been about steady progress and cultivating meaningful connections to accelerate the growth trajectory of our portfolio companies. 

ArteraAI Secures $20 Million in Funding to Further Personalize Cancer Therapy With Multimodal AI

ArteraAI Secures $20 Million in Funding to Further Personalize Cancer Therapy With Multimodal AI

ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tests, announced today that it has secured an additional $20 million in capital fueled by several prominent large investment funds including Prosperity7 Ventures, Singapore-based global investor EDBI, Walden Catalyst Ventures, Wilson Sonsini Goodrich & Rosati, and Trium Ventures, along with investors Navin Chaddha, Rajiv Khemani (AISpace VC), and Andrew & Elliott Tan (A&E Investment LLC).